Hosted on MSN3h
New children's pain clinic to open in San Francisco this spring
A new hospital center specializing in pediatric pain and palliative care will open its doors this spring at UCSF Benioff's ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
FDA approves first new non-opioid pain pill in decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
clinicalpainadvisor.com12h
Chronic Pain Among Women in Rheumatology — Prioritizing Unmet Needs
Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
KCBS Radio San Francisco on MSN2d
As Prescribed: The evolving landscape of chronic pain treatment
Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...
News Medical3d
New brain biomarker identifies pain sensitivity and may predict chronic pain risk
A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...